ResMed (RMD) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.88, $0.10 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.15 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
